OBJECTIVES: Cigarette smoking is highly prevalent among individuals with bipolar disorder (BD) and may adversely affect symptoms of the disorder, as well as the co-occurrence of other substance use disorders. However, anecdotal reports suggesting that smoking cessation caused a worsening of mood in smokers with BD have raised concerns about quitting. In the present study, we prospectively evaluated the course of BD, alcohol use disorders, and cannabis use disorders in relation to smoking and examined the relationship between smoking abstinence and changes in mood. METHODS: Participants (N = 161) were adolescents (n=80) and adults (n = 81) with bipolar I disorder who were hospitalized for their initial mixed or manic episode. Participants were followed up to eight years post-hospitalization (median follow-up = 122 weeks) as part of a naturalistic, observational study of the longitudinal course of BD and substance use. RESULTS: The course of BD symptoms in the 12 months following index hospitalization did not differ by smoking status in either the adolescent or the adult subsample. Among adolescents, smoking was associated with an increased risk of having a cannabis or alcohol use disorder, almost all of which were new-onset disorders, in the year following first hospitalization. Neither adolescents nor adults who were abstinent from smoking for at least two months experienced significant increases in depressive or manic symptoms. CONCLUSIONS: Although cigarette smoking did not predict a worse course of BD, smoking was associated with an increased risk of developing alcohol and cannabis use disorders in adolescents with BD. Importantly, these data provide no evidence to suggest that abstinence from smoking is associated with worsening symptoms of depression or mania in the short term.
OBJECTIVES: Cigarette smoking is highly prevalent among individuals with bipolar disorder (BD) and may adversely affect symptoms of the disorder, as well as the co-occurrence of other substance use disorders. However, anecdotal reports suggesting that smoking cessation caused a worsening of mood in smokers with BD have raised concerns about quitting. In the present study, we prospectively evaluated the course of BD, alcohol use disorders, and cannabis use disorders in relation to smoking and examined the relationship between smoking abstinence and changes in mood. METHODS:Participants (N = 161) were adolescents (n=80) and adults (n = 81) with bipolar I disorder who were hospitalized for their initial mixed or manic episode. Participants were followed up to eight years post-hospitalization (median follow-up = 122 weeks) as part of a naturalistic, observational study of the longitudinal course of BD and substance use. RESULTS: The course of BD symptoms in the 12 months following index hospitalization did not differ by smoking status in either the adolescent or the adult subsample. Among adolescents, smoking was associated with an increased risk of having a cannabis or alcohol use disorder, almost all of which were new-onset disorders, in the year following first hospitalization. Neither adolescents nor adults who were abstinent from smoking for at least two months experienced significant increases in depressive or manic symptoms. CONCLUSIONS: Although cigarette smoking did not predict a worse course of BD, smoking was associated with an increased risk of developing alcohol and cannabis use disorders in adolescents with BD. Importantly, these data provide no evidence to suggest that abstinence from smoking is associated with worsening symptoms of depression or mania in the short term.
Authors: Melissa P DelBello; Dennis Hanseman; Caleb M Adler; David E Fleck; Stephen M Strakowski Journal: Am J Psychiatry Date: 2007-04 Impact factor: 18.112
Authors: Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori Journal: JAMA Date: 2010-12-08 Impact factor: 56.272
Authors: Andrea H Weinberger; Jennifer C Vessicchio; Kristi A Sacco; Cerissa L Creeden; K N Roy Chengappa; Tony P George Journal: J Clin Psychopharmacol Date: 2008-10 Impact factor: 3.153
Authors: Francisco J Diaz; Danielle James; Sheila Botts; Lorraine Maw; Margaret T Susce; Jose de Leon Journal: Bipolar Disord Date: 2009-03 Impact factor: 6.744
Authors: Jaimee L Heffner; Melissa P DelBello; David E Fleck; Robert M Anthenelli; Stephen M Strakowski Journal: Bipolar Disord Date: 2008-11 Impact factor: 6.744
Authors: Andrea H Weinberger; Brian Hitsman; George D Papandonatos; Kristi A Sacco; Jennifer C Vessicchio; Tony P George Journal: J Clin Psychopharmacol Date: 2009-12 Impact factor: 3.153
Authors: Judith J Prochaska; Sharon M Hall; Janice Y Tsoh; Stuart Eisendrath; Joseph S Rossi; Colleen A Redding; Amy B Rosen; Marc Meisner; Gary L Humfleet; Julie A Gorecki Journal: Am J Public Health Date: 2007-06-28 Impact factor: 9.308
Authors: Jacob R Stephens; Jaimee L Heffner; Caleb M Adler; Thomas J Blom; Robert M Anthenelli; David E Fleck; Jeffrey A Welge; Stephen M Strakowski; Melissa P DelBello Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-05-10 Impact factor: 8.829
Authors: José M Martínez-Ortega; Benjamin I Goldstein; Luis Gutiérrez-Rojas; Regina Sala; Shuai Wang; Carlos Blanco Journal: J Psychiatr Res Date: 2013-04-11 Impact factor: 4.791
Authors: Jaimee L Heffner; Robert M Anthenelli; Caleb M Adler; Stephen M Strakowski; Jennifer Beavers; Melissa P DelBello Journal: Psychiatry Res Date: 2013-05-17 Impact factor: 3.222
Authors: Sung-Wan Kim; Seetal Dodd; Lesley Berk; Jayashri Kulkarni; Anthony de Castella; Paul B Fitzgerald; Jae-Min Kim; Jin-Sang Yoon; Michael Berk Journal: Psychiatry Investig Date: 2015-07-06 Impact factor: 2.505